The effect of nutraceuticals on multiple signaling pathways in cardiac fibrosis injury and repair
- PMID: 32495263
- DOI: 10.1007/s10741-020-09980-6
The effect of nutraceuticals on multiple signaling pathways in cardiac fibrosis injury and repair
Abstract
Cardiac fibrosis is one of the most common pathological conditions caused by different heart diseases, including myocardial infarction and diabetic cardiomyopathy. Cardiovascular disease is one of the major causes of mortality worldwide. Cardiac fibrosis is caused by different processes, including inflammatory reactions and oxidative stress. The process of fibrosis begins by changing the balance between production and destruction of extracellular matrix components and stimulating the proliferation and differentiation of cardiac fibroblasts. Many studies have focused on finding drugs with less adverse effects for the treatment of cardiovascular disease. Some studies show that nutraceuticals are effective in preventing and treating diseases, including cardiovascular disease, and that they can reduce the risk. However, big clinical studies to prove the therapeutic properties of all these substances and their adverse effects are lacking so far. Therefore, in this review, we tried to summarize the knowledge on pathways and mechanisms of several nutraceuticals which have shown their usefulness in the prevention of cardiac fibrosis.
Keywords: Cardiac fibrosis; Cardiovascular disease; Inflammatory markers; Nutraceuticals; Oxidative stress.
© 2020. Springer Science+Business Media, LLC, part of Springer Nature.
Similar articles
-
Syndecans in heart fibrosis.Cell Tissue Res. 2016 Sep;365(3):539-52. doi: 10.1007/s00441-016-2454-2. Epub 2016 Jul 14. Cell Tissue Res. 2016. PMID: 27411689 Review.
-
Resveratrol and Cardiac Fibrosis Prevention and Treatment.Curr Pharm Biotechnol. 2022;23(2):190-200. doi: 10.2174/1389201022666210212125003. Curr Pharm Biotechnol. 2022. PMID: 33583368 Review.
-
Featured Article: TGF-β1 dominates extracellular matrix rigidity for inducing differentiation of human cardiac fibroblasts to myofibroblasts.Exp Biol Med (Maywood). 2018 Apr;243(7):601-612. doi: 10.1177/1535370218761628. Epub 2018 Mar 4. Exp Biol Med (Maywood). 2018. PMID: 29504479 Free PMC article.
-
Oligomeric proanthocyanidins protect myocardium by mitigating left ventricular remodeling in isoproterenol-induced postmyocardial infarction.Fundam Clin Pharmacol. 2018 Feb;32(1):51-59. doi: 10.1111/fcp.12325. Epub 2017 Nov 15. Fundam Clin Pharmacol. 2018. PMID: 29059499
-
The effector cells and cellular mediators of immune system involved in cardiac inflammation and fibrosis after myocardial infarction.J Cell Physiol. 2020 Dec;235(12):8996-9004. doi: 10.1002/jcp.29732. Epub 2020 Apr 30. J Cell Physiol. 2020. PMID: 32352172 Review.
Cited by
-
Post-myocardial infarction fibrosis: Pathophysiology, examination, and intervention.Front Pharmacol. 2023 Mar 28;14:1070973. doi: 10.3389/fphar.2023.1070973. eCollection 2023. Front Pharmacol. 2023. PMID: 37056987 Free PMC article. Review.
References
-
- Gu HP, Lin S, Xu M, Yu HY, du XJ, Zhang YY, Yuan G, Gao W (2012) Up-regulating relaxin expression by G-quadruplex interactive ligand to achieve antifibrotic action. Endocrinology 153:3692–3700 - PubMed
-
- Yu C-M, Tipoe GL, Lai KW-H, Lau C-P (2001) Effects of combination of angiotensin-converting enzyme inhibitor and angiotensin receptor antagonist on inflammatory cellular infiltration and myocardial interstitial fibrosis after acute myocardial infarction. J Am Coll Cardiol 38:1207–1215 - PubMed
-
- Querejeta R, López B, González A et al (2004) Increased collagen type I synthesis in patients with heart failure of hypertensive origin: relation to myocardial fibrosis. Circulation 110:1263–1268 - PubMed
-
- Li L, Zhao Q, Kong W (2018) Extracellular matrix remodeling and cardiac fibrosis. Matrix Biol 68-69:490–506 - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical